Prediction of Antimicrobial Resistance in People Living With Cystic Fibrosis Using Machine Learning. [PDF]
Jiang J +10 more
europepmc +1 more source
A Ten-Year Trend of Antimicrobial Resistance in <i>Pseudomonas aeruginosa</i> From United States Medical Centers: Results From the INFORM Surveillance Program (2015-2024). [PDF]
Sader HS +4 more
europepmc +1 more source
Active surveillance and risk prediction of piperacillin/tazobactam‑associated hypokalaemia: development and external validation of a clinical nomogram. [PDF]
Bai H, Guo M, Zheng N, Nie X.
europepmc +1 more source
Evaluation of Short Versus Long Course of Tobramycin Combined with Piperacillin/Tazobactam Against Antibiotic-Resistant <i>Pseudomonas aeruginosa</i> in a Hollow Fibre Infection Model. [PDF]
Wale YM +8 more
europepmc +1 more source
Polymicrobial Catheter-Related Bloodstream Infection Involving <i>Brevundimonas diminuta</i> and <i>Streptococcus anginosus</i>: A Case Report and Literature Review. [PDF]
Huang PH +6 more
europepmc +1 more source
β-lactam infusion strategies in critical illness: is continuous superior to extended infusion? A systematic review and network meta-analysis. [PDF]
Peng F +9 more
europepmc +1 more source
Microbiology and Antimicrobial Resistance of Surgical Site Infection After Inflammatory Bowel Disease Surgery: Prophylaxis-Spectrum Discordance in a Retrospective Cohort from Saudi Arabia. [PDF]
Farsi AH +7 more
europepmc +1 more source
Factors Affecting Vancomycin and Piperacillin-Tazobactam-Induced Nephrotoxicity. [PDF]
Day MV, Munshi R, Picard K, Malek AE.
europepmc +1 more source
A multicentre evaluation of pharmacokinetic/pharmacodynamic target attainment of piperacillin and tazobactam and the association with clinical outcomes in critically ill patients with sepsis and septic shock. [PDF]
Sulaiman H +13 more
europepmc +1 more source

